U.S. stocks extended losses as poor earnings from Gilead Sciences (GILD) dragged the entire health care sector lower. Markets were also down after a monthly reading on consumer activity in the U.S. showed a tendency to save instead of spend. Consumer sentiment fell in April as Americans grew more concerned over future economic conditions. This marks the fourth straight monthly decline. Economic activity in the Chicago area weakened in April as a softer global economy tempered demand for U.S. products. The Chicago PMI was just above the level that separates expansion from contraction. Rovi (ROVI) announced that it had reached an agreement to buy Tivo (TIVO) for around $1.1 billion in a cash-and-stock deal. The companies expect annual cost synergies of at least $100 million. TheStreet's Keris Lahiff reports from Wall Street.
More from Video
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.
Is Renewable Energy the Defensive Stock Opportunity You're Missing
AMSC CEO discusses that and China challenges.
Takeda Pharmaceutical CEO Talks Big Pharma Trends
One of pharma's biggest CEO's talks M&A action on the exchange.
Real Money Video Wrap: Citi Surges as View of Stability Saves Sentiment
Citi overcame a mixed print to send its stock surging on Monday.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.